Aldeyra expects cash to fund operations into 2029
ALDX•Aldeyra Therapeutics expects its cash and cash equivalents to fund operations into 2029. It had $41 million in cash and cash equivalents as of September 30, 2026.
1. Cash runway
Aldeyra Therapeutics expects its cash and cash equivalents to fund operations into 2029. The company had $41 million in cash and cash equivalents as of September 30, 2026.
